Logo image of SCANA.OL

SCANA ASA (SCANA.OL) Stock Fundamental Analysis

OSL:SCANA - Euronext Oslo - NO0003053308 - Common Stock - Currency: NOK

1.589  -0.04 (-2.16%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SCANA. SCANA was compared to 108 industry peers in the Machinery industry. SCANA has a medium profitability rating, but doesn't score so well on its financial health evaluation. An interesting combination arises when we look at growth and value: SCANA is growing strongly while it also seems undervalued.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SCANA had positive earnings in the past year.
SCANA had a positive operating cash flow in the past year.
SCANA had positive earnings in 4 of the past 5 years.
In the past 5 years SCANA always reported a positive cash flow from operatings.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

SCANA has a worse Return On Assets (0.65%) than 64.81% of its industry peers.
SCANA's Return On Equity of 1.56% is on the low side compared to the rest of the industry. SCANA is outperformed by 66.67% of its industry peers.
With a Return On Invested Capital value of 3.15%, SCANA is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.65%
ROE 1.56%
ROIC 3.15%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

Looking at the Profit Margin, with a value of 0.55%, SCANA is doing worse than 67.59% of the companies in the same industry.
In the last couple of years the Profit Margin of SCANA has grown nicely.
Looking at the Operating Margin, with a value of 2.36%, SCANA is doing worse than 74.07% of the companies in the same industry.
In the last couple of years the Operating Margin of SCANA has grown nicely.
SCANA's Gross Margin of 54.88% is fine compared to the rest of the industry. SCANA outperforms 72.22% of its industry peers.
SCANA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.36%
PM (TTM) 0.55%
GM 54.88%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SCANA is destroying value.
The number of shares outstanding for SCANA has been increased compared to 1 year ago.
Compared to 5 years ago, SCANA has more shares outstanding
The debt/assets ratio for SCANA has been reduced compared to a year ago.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of SCANA is 7.98, which is on the high side as it means it would take SCANA, 7.98 years of fcf income to pay off all of its debts.
SCANA has a Debt to FCF ratio (7.98) which is comparable to the rest of the industry.
SCANA has a Debt/Equity ratio of 0.60. This is a neutral value indicating SCANA is somewhat dependend on debt financing.
SCANA has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: SCANA underperforms 63.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.98
Altman-Z N/A
ROIC/WACC0.39
WACC8.03%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.03 indicates that SCANA should not have too much problems paying its short term obligations.
SCANA has a worse Current ratio (1.03) than 83.33% of its industry peers.
A Quick Ratio of 0.78 indicates that SCANA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.78, SCANA is doing worse than 70.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.78
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

SCANA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.11%.
Measured over the past years, SCANA shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.20% on average per year.
Looking at the last year, SCANA shows a small growth in Revenue. The Revenue has grown by 2.94% in the last year.
SCANA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.74% yearly.
EPS 1Y (TTM)-93.11%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-162.54%
Revenue 1Y (TTM)2.94%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-31.93%

3.2 Future

The Earnings Per Share is expected to grow by 34.80% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.21% on average over the next years. This is quite good.
EPS Next Y19.33%
EPS Next 2Y39.53%
EPS Next 3Y34.8%
EPS Next 5YN/A
Revenue Next Year1.92%
Revenue Next 2Y9.54%
Revenue Next 3Y10.21%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.93 indicates a reasonable valuation of SCANA.
SCANA's Price/Earnings ratio is rather cheap when compared to the industry. SCANA is cheaper than 82.41% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. SCANA is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 4.98, which indicates a rather cheap valuation of SCANA.
SCANA's Price/Forward Earnings ratio is rather cheap when compared to the industry. SCANA is cheaper than 96.30% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SCANA to the average of the S&P500 Index (22.19), we can say SCANA is valued rather cheaply.
Industry RankSector Rank
PE 9.93
Fwd PE 4.98
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCANA is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, SCANA is valued a bit cheaper than 72.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.58
EV/EBITDA 8.27
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SCANA's earnings are expected to grow with 34.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)0.47
EPS Next 2Y39.53%
EPS Next 3Y34.8%

0

5. Dividend

5.1 Amount

SCANA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SCANA ASA

OSL:SCANA (6/20/2025, 4:10:46 PM)

1.589

-0.04 (-2.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)N/A N/A
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners10.16%
Ins Owner ChangeN/A
Market Cap733.94M
Analysts86.67
Price Target3.47 (118.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-61.68%
DP228.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.39%
Min Revenue beat(2)-19.55%
Max Revenue beat(2)0.77%
Revenue beat(4)2
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-19.55%
Max Revenue beat(4)9.63%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.93
Fwd PE 4.98
P/S 0.41
P/FCF 10.58
P/OCF 4.94
P/B 1.16
P/tB 2.89
EV/EBITDA 8.27
EPS(TTM)0.16
EY10.07%
EPS(NY)0.32
Fwd EY20.09%
FCF(TTM)0.15
FCFY9.46%
OCF(TTM)0.32
OCFY20.26%
SpS3.89
BVpS1.38
TBVpS0.55
PEG (NY)0.51
PEG (5Y)0.47
Profitability
Industry RankSector Rank
ROA 0.65%
ROE 1.56%
ROCE 4.15%
ROIC 3.15%
ROICexc 3.15%
ROICexgc 5.04%
OM 2.36%
PM (TTM) 0.55%
GM 54.88%
FCFM 3.86%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-3.16%
ROICexcg growth 5Y183.75%
ROICexc growth 3Y-15.99%
ROICexc growth 5Y161.08%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.98
Debt/EBITDA 2.44
Cap/Depr 68.96%
Cap/Sales 4.41%
Interest Coverage 1.18
Cash Conversion 94.47%
Profit Quality 701.01%
Current Ratio 1.03
Quick Ratio 0.78
Altman-Z N/A
F-Score6
WACC8.03%
ROIC/WACC0.39
Cap/Depr(3y)42.24%
Cap/Depr(5y)32.52%
Cap/Sales(3y)2.81%
Cap/Sales(5y)1.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.11%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-162.54%
EPS Next Y19.33%
EPS Next 2Y39.53%
EPS Next 3Y34.8%
EPS Next 5YN/A
Revenue 1Y (TTM)2.94%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-31.93%
Revenue Next Year1.92%
Revenue Next 2Y9.54%
Revenue Next 3Y10.21%
Revenue Next 5YN/A
EBIT growth 1Y-68.07%
EBIT growth 3Y125.68%
EBIT growth 5Y359.05%
EBIT Next Year82.48%
EBIT Next 3Y36.44%
EBIT Next 5YN/A
FCF growth 1Y6.76%
FCF growth 3Y41.29%
FCF growth 5Y3.96%
OCF growth 1Y81.15%
OCF growth 3Y80.15%
OCF growth 5Y20.9%